Clinical Trial

Acute Immune Modulation by Probiotic Strain

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical proof-of-concept study, comparing the acute immune impacts of 3 doses of a probiotic strain to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 3 different doses of the probiotic at different times. Testing for immune status and cytokine levels will be conducted to determine the acute impact of the probiotic on immune function when compared to a placebo.
Trial Details
NCT Number NCT06754228
Lead Sponsor Natural Immune Systems Inc
Collaborators: Jeneil Biotech Inc.
Conditions Immune Surveillance
Enrollment 24 participants
Start Date 2024-11-13
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-31